Biohit Oyj B Stock Beta
| BIOBV Stock | EUR 2.33 0.00 0.00% |
Biohit Oyj B fundamentals help investors to digest information that contributes to Biohit Oyj's financial success or failures. It also enables traders to predict the movement of Biohit Stock. The fundamental analysis module provides a way to measure Biohit Oyj's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biohit Oyj stock.
Biohit |
Biohit Oyj B Company Beta Analysis
Biohit Oyj's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Biohit Oyj Beta | 1.02 |
Most of Biohit Oyj's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biohit Oyj B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Biohit Oyj B has a Beta of 1.0168. This is 18.23% higher than that of the Health Care Equipment & Supplies sector and 26.85% lower than that of the Health Care industry. The beta for all Finland stocks is notably lower than that of the firm.
Biohit Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biohit Oyj's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biohit Oyj could also be used in its relative valuation, which is a method of valuing Biohit Oyj by comparing valuation metrics of similar companies.Biohit Oyj is currently under evaluation in beta category among its peers.
Biohit Oyj returns are very sensitive to returns on the market. As the market goes up or down, Biohit Oyj is expected to follow.
Biohit Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 20.88 M | |||
| Shares Outstanding | 12.07 M | |||
| Shares Owned By Insiders | 47.13 % | |||
| Price To Earning | 11.00 X | |||
| Price To Book | 3.28 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 9.36 M | |||
| Gross Profit | 5.92 M | |||
| EBITDA | 693 K | |||
| Net Income | (1.5 M) | |||
| Cash And Equivalents | 9.38 M | |||
| Cash Per Share | 0.63 X | |||
| Total Debt | 59 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 7.79 X | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | (444 K) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 3.8 | |||
| Number Of Employees | 44 | |||
| Beta | 1.02 | |||
| Market Capitalization | 30.69 M | |||
| Total Asset | 9.61 M | |||
| Retained Earnings | 6 M | |||
| Working Capital | 8 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 1000 K | |||
| Net Asset | 9.61 M |
About Biohit Oyj Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biohit Oyj B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biohit Oyj using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biohit Oyj B based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.